Scollr summary
What this paper is about
Intratumoral injection of recombinant murine IL-12 (r-mIL-12) significantly prolonged mouse survival and suppressed tumor growth in immunocompetent mice, suggesting that local administration of r-mIL-12 may serve as an effective therapeutic approach for OSCC with mandibular bone invasion.
Full abstract
Read the full abstract
OBJECTIVE: Oral squamous cell carcinoma (OSCC) frequently invades the mandibular bone, leading to metastasis and poor prognosis. This study aimed to evaluate the therapeutic effects of locally administered interleukin-12 (IL-12) using an immunocompetent mouse model mimicking the clinical features of mandibular bone invasion. METHODS: The effects of IL-12 on tumor growth and bone resorption were evaluated using subcutaneous and bone invasion models of OSCC in both immunocompetent and athymic mice. Bone resorption was assessed by micro-computed tomography (CT). In addition, quantitative polymerase chain reaction (qPCR) was performed to quantify the expression of osteoclast markers (Acp5, Ctsk) and immune-related genes (Ifng, Fasl). RESULTS: Intratumoral injection of recombinant murine IL-12 (r-mIL-12) significantly prolonged mouse survival and suppressed tumor growth in immunocompetent mice. Micro-CT revealed reduced bone resorption in the r-mIL-12-treated group. Consistently, qPCR demonstrated downregulation of Acp5 and Ctsk, along with upregulation of Ifng and Fasl compared to controls. In contrast, r-mIL-12 treatment had no significant effect on tumor growth or bone resorption in athymic mice, underscoring the importance of T cells in controlling bone invasion. CONCLUSIONS: These findings suggest that local administration of r-mIL-12 may serve as an effective therapeutic approach for OSCC with mandibular bone invasion.
Direct answer
What can I do from this paper page?
Use this page to scan "Intratumoral Administration of Recombinant Murine Interleukin‐12 Prevents Tumor Progression and Bone Invasion" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Cytokine Signaling Pathways and Interactions research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Kasahara2026Intratumoral,
title = {Intratumoral Administration of Recombinant Murine Interleukin‐12 Prevents Tumor Progression and Bone Invasion},
author = {Shun Kasahara and Miki Kashiwagi and Toshihiro Inubushi and Akinari Sugauchi and Wu Deyong and Kyoko Kurioka and Kazuaki Miyagawa and Takuma Matsuda and S Seki and Mikihiko Kogo and Susumu Tanaka and Toshihiro Uchihashi},
journal = {Oral Diseases},
year = {2026},
doi = {10.1111/odi.70399},
url = {https://doi.org/10.1111/odi.70399}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Cytokine Signaling Pathways and Interactions research papers?
Follow Cytokine Signaling Pathways and Interactions research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Intratumoral Administration of Recombinant Murine Interleukin‐12 Prevents Tumor Progression and Bone Invasion. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app